| Kathleen Nicole Dawood, NP | |
|
Sigonella Us Naval Hospital, Building #273, Fpo, AE 09636 | |
| (757) 635-7624 | |
| Not Available |
| Full Name | Kathleen Nicole Dawood |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner - Family |
| Location | Sigonella Us Naval Hospital, Fpo, Armed Forces Europe |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1104523794 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LF0000X | Nurse Practitioner - Family | 0024186432 (Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kathleen Nicole Dawood, NP Psc 836 Box 432, Fpo, AE 09636-0008 Ph: (757) 635-7624 | Kathleen Nicole Dawood, NP Sigonella Us Naval Hospital, Building #273, Fpo, AE 09636 Ph: (757) 635-7624 |
News Archive
The World NET Community announces the first Worldwide NET Cancer Awareness Day on November 10, 2010 to raise awareness about cancers called neuroendocrine tumors (NETs) and the need for timely detection and diagnosis. More than 90% of all NET patients are incorrectly diagnosed and initially treated for the wrong disease. Misdiagnoses or delayed diagnoses mean that NET patients are treated on average five to seven years for the wrong disease; often the correct diagnosis is not made until the disease has spread (metastasized).
Shire plc, the global specialty biopharmaceutical company, today announces the publication in Clinical Nephrology of findings from a head-to-head clinical study comparing the efficacy of two non-calcium based phosphate binders, FOSRENOL(R) (lanthanum carbonate) and sevelamer hydrochloride (Genzyme's Renagel(R)) in chronic kidney disease (CKD) patients on haemodialysis.
A recent upsurge in people with mental illness seeking treatment in emergency departments is taking a significant toll on patient care and hospital resources nationwide, according to a new survey of emergency physicians conducted by the nation's leading mental health organizations and the American College of Emergency Physicians.
Harbor Biosciences, a biopharmaceutical company developing novel therapeutics for the treatment of cancer, metabolic and inflammatory diseases, today released an update to its development program for Triolex to treat obesity-induced insulin resistance and type-2 diabetes mellitus (T2DM).
The multi-billion-dollar global cosmetics and skin-care-product industry sometimes is beset by a me-too mindset in which research and development focuses on matching the competition rather than applying sound science to improve products, a scientist told the 234th national meeting of the American Chemical Society.
› Verified 7 days ago
Mrs. Sondra Michelle Santana, ANP-BC Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Uss Enterprise Cvn 65, Medical Department, Box 47, Fpo, AE 09543 Phone: 757-534-3778 | |
Dr. Terri Collins, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Psc 836 Box 2670, Fpo, AE 09636 Phone: 011-390-9556 | |
Ms. Heather Ann Shattuck, ACNP-BC Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 836 Box 2670, Fpo, AE 09636 Phone: 348-719-7007 | |
Kenneth Lee Hopkins, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 827, Box 119, Fpo, AE 09617 Phone: 011-390-818116263 |